Oxytocin Add on Study for Stable Schizophrenic Patients (Oxytocin)
This study has suspended participant recruitment.
(Break in funding)
Stanley Medical Research Institute
Information provided by (Responsible Party):
David Feifel, University of California, San Diego
First received: July 23, 2007
Last updated: January 11, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has suspended participant recruitment.|
|Estimated Study Completion Date:||December 2018|
|Estimated Primary Completion Date:||December 2018 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Feifel D, Macdonald K, Cobb P, Minassian A. Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia. Schizophr Res. 2012 Aug;139(1-3):207-10. doi: 10.1016/j.schres.2012.05.018.